Clinical benefit of metaphase I oocytes

BACKGROUND: We studied the benefit of using in vitro matured metaphase I (MI) oocytes for ICSI in patients with a maximum of 6 mature metaphase II (MII) oocytes at retrieval. METHODS: In 2004, 187 ICSI cycles were selected in which maximum 6 MII oocytes and at least one MI oocyte were retrieved. MI...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanhoutte, Leen, De Sutter, Petra, Van der Elst, Josiane, Dhont, Marc
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1325026/
https://www.ncbi.nlm.nih.gov/pubmed/16356175
http://dx.doi.org/10.1186/1477-7827-3-71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1325026/
https://www.ncbi.nlm.nih.gov/pubmed/16356175
http://dx.doi.org/10.1186/1477-7827-3-71

Ejemplares similares